Global Psoriasis Drugs Market Insights and Forecast to 2028

SKU ID : QYR-20051120 | Publishing Date : 31-Jan-2022 | No. of pages : 95

Request a free Sample

Detailed TOC of Global Psoriasis Drugs Market Insights and Forecast to 2028

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Psoriasis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Tumor Necrosis Factor Inhibitor
        1.2.3 Interleukin Inhibitors
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Psoriasis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Topicals
        1.3.3 Systemic
        1.3.4 Biologics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Psoriasis Drugs Market Perspective (2017-2028)
    2.2 Psoriasis Drugs Growth Trends by Region
        2.2.1 Psoriasis Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Psoriasis Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Psoriasis Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Psoriasis Drugs Market Dynamics
        2.3.1 Psoriasis Drugs Industry Trends
        2.3.2 Psoriasis Drugs Market Drivers
        2.3.3 Psoriasis Drugs Market Challenges
        2.3.4 Psoriasis Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Psoriasis Drugs Players by Revenue
        3.1.1 Global Top Psoriasis Drugs Players by Revenue (2017-2022)
        3.1.2 Global Psoriasis Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Psoriasis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Psoriasis Drugs Revenue
    3.4 Global Psoriasis Drugs Market Concentration Ratio
        3.4.1 Global Psoriasis Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Drugs Revenue in 2021
    3.5 Psoriasis Drugs Key Players Head office and Area Served
    3.6 Key Players Psoriasis Drugs Product Solution and Service
    3.7 Date of Enter into Psoriasis Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Drugs Breakdown Data by Type
    4.1 Global Psoriasis Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Psoriasis Drugs Forecasted Market Size by Type (2023-2028)
5 Psoriasis Drugs Breakdown Data by Application
    5.1 Global Psoriasis Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Psoriasis Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Psoriasis Drugs Market Size (2017-2028)
    6.2 North America Psoriasis Drugs Market Size by Type
        6.2.1 North America Psoriasis Drugs Market Size by Type (2017-2022)
        6.2.2 North America Psoriasis Drugs Market Size by Type (2023-2028)
        6.2.3 North America Psoriasis Drugs Market Share by Type (2017-2028)
    6.3 North America Psoriasis Drugs Market Size by Application
        6.3.1 North America Psoriasis Drugs Market Size by Application (2017-2022)
        6.3.2 North America Psoriasis Drugs Market Size by Application (2023-2028)
        6.3.3 North America Psoriasis Drugs Market Share by Application (2017-2028)
    6.4 North America Psoriasis Drugs Market Size by Country
        6.4.1 North America Psoriasis Drugs Market Size by Country (2017-2022)
        6.4.2 North America Psoriasis Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Psoriasis Drugs Market Size (2017-2028)
    7.2 Europe Psoriasis Drugs Market Size by Type
        7.2.1 Europe Psoriasis Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Psoriasis Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Psoriasis Drugs Market Share by Type (2017-2028)
    7.3 Europe Psoriasis Drugs Market Size by Application
        7.3.1 Europe Psoriasis Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Psoriasis Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Psoriasis Drugs Market Share by Application (2017-2028)
    7.4 Europe Psoriasis Drugs Market Size by Country
        7.4.1 Europe Psoriasis Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Psoriasis Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Psoriasis Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Psoriasis Drugs Market Size by Type
        8.2.1 Asia-Pacific Psoriasis Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Psoriasis Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Psoriasis Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Psoriasis Drugs Market Size by Application
        8.3.1 Asia-Pacific Psoriasis Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Psoriasis Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Psoriasis Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Psoriasis Drugs Market Size by Region
        8.4.1 Asia-Pacific Psoriasis Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Psoriasis Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia
9 Latin America
    9.1 Latin America Psoriasis Drugs Market Size (2017-2028)
    9.2 Latin America Psoriasis Drugs Market Size by Type
        9.2.1 Latin America Psoriasis Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Psoriasis Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Psoriasis Drugs Market Share by Type (2017-2028)
    9.3 Latin America Psoriasis Drugs Market Size by Application
        9.3.1 Latin America Psoriasis Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Psoriasis Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Psoriasis Drugs Market Share by Application (2017-2028)
    9.4 Latin America Psoriasis Drugs Market Size by Country
        9.4.1 Latin America Psoriasis Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Psoriasis Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Psoriasis Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Psoriasis Drugs Market Size by Type
        10.2.1 Middle East & Africa Psoriasis Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Psoriasis Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Psoriasis Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Psoriasis Drugs Market Size by Application
        10.3.1 Middle East & Africa Psoriasis Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Psoriasis Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Psoriasis Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Psoriasis Drugs Market Size by Country
        10.4.1 Middle East & Africa Psoriasis Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Psoriasis Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Psoriasis Drugs Introduction
        11.1.4 AbbVie Revenue in Psoriasis Drugs Business (2017-2022)
        11.1.5 AbbVie Recent Developments
    11.2 Amgen
        11.2.1 Amgen Company Details
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Psoriasis Drugs Introduction
        11.2.4 Amgen Revenue in Psoriasis Drugs Business (2017-2022)
        11.2.5 Amgen Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Psoriasis Drugs Introduction
        11.3.4 Johnson & Johnson Revenue in Psoriasis Drugs Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Psoriasis Drugs Introduction
        11.4.4 Novartis Revenue in Psoriasis Drugs Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 Eli Lilly & Company
        11.5.1 Eli Lilly & Company Company Details
        11.5.2 Eli Lilly & Company Business Overview
        11.5.3 Eli Lilly & Company Psoriasis Drugs Introduction
        11.5.4 Eli Lilly & Company Revenue in Psoriasis Drugs Business (2017-2022)
        11.5.5 Eli Lilly & Company Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Psoriasis Drugs Introduction
        11.6.4 AstraZeneca Revenue in Psoriasis Drugs Business (2017-2022)
        11.6.5 AstraZeneca Recent Developments
    11.7 Celgene Corporation
        11.7.1 Celgene Corporation Company Details
        11.7.2 Celgene Corporation Business Overview
        11.7.3 Celgene Corporation Psoriasis Drugs Introduction
        11.7.4 Celgene Corporation Revenue in Psoriasis Drugs Business (2017-2022)
        11.7.5 Celgene Corporation Recent Developments
    11.8 UCB
        11.8.1 UCB Company Details
        11.8.2 UCB Business Overview
        11.8.3 UCB Psoriasis Drugs Introduction
        11.8.4 UCB Revenue in Psoriasis Drugs Business (2017-2022)
        11.8.5 UCB Recent Developments
    11.9 Merck
        11.9.1 Merck Company Details
        11.9.2 Merck Business Overview
        11.9.3 Merck Psoriasis Drugs Introduction
        11.9.4 Merck Revenue in Psoriasis Drugs Business (2017-2022)
        11.9.5 Merck Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Figures, Tables and Charts Available in Global Psoriasis Drugs Market Insights and Forecast to 2028

List of Tables
    Table 1. Global Psoriasis Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Tumor Necrosis Factor Inhibitor
    Table 3. Key Players of Interleukin Inhibitors
    Table 4. Key Players of Others
    Table 5. Global Psoriasis Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Psoriasis Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Psoriasis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Psoriasis Drugs Market Share by Region (2017-2022)
    Table 9. Global Psoriasis Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Psoriasis Drugs Market Share by Region (2023-2028)
    Table 11. Psoriasis Drugs Market Trends
    Table 12. Psoriasis Drugs Market Drivers
    Table 13. Psoriasis Drugs Market Challenges
    Table 14. Psoriasis Drugs Market Restraints
    Table 15. Global Psoriasis Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Psoriasis Drugs Revenue Share by Players (2017-2022)
    Table 17. Global Top Psoriasis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Drugs as of 2021)
    Table 18. Ranking of Global Top Psoriasis Drugs Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Psoriasis Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Psoriasis Drugs Product Solution and Service
    Table 22. Date of Enter into Psoriasis Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Psoriasis Drugs Revenue Market Share by Type (2017-2022)
    Table 26. Global Psoriasis Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Psoriasis Drugs Revenue Market Share by Type (2023-2028)
    Table 28. Global Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Psoriasis Drugs Revenue Share by Application (2017-2022)
    Table 30. Global Psoriasis Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Psoriasis Drugs Revenue Share by Application (2023-2028)
    Table 32. North America Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Psoriasis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Psoriasis Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 62. AbbVie Company Details
    Table 63. AbbVie Business Overview
    Table 64. AbbVie Psoriasis Drugs Product
    Table 65. AbbVie Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 66. AbbVie Recent Developments
    Table 67. Amgen Company Details
    Table 68. Amgen Business Overview
    Table 69. Amgen Psoriasis Drugs Product
    Table 70. Amgen Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 71. Amgen Recent Developments
    Table 72. Johnson & Johnson Company Details
    Table 73. Johnson & Johnson Business Overview
    Table 74. Johnson & Johnson Psoriasis Drugs Product
    Table 75. Johnson & Johnson Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 76. Johnson & Johnson Recent Developments
    Table 77. Novartis Company Details
    Table 78. Novartis Business Overview
    Table 79. Novartis Psoriasis Drugs Product
    Table 80. Novartis Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 81. Novartis Recent Developments
    Table 82. Eli Lilly & Company Company Details
    Table 83. Eli Lilly & Company Business Overview
    Table 84. Eli Lilly & Company Psoriasis Drugs Product
    Table 85. Eli Lilly & Company Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 86. Eli Lilly & Company Recent Developments
    Table 87. AstraZeneca Company Details
    Table 88. AstraZeneca Business Overview
    Table 89. AstraZeneca Psoriasis Drugs Product
    Table 90. AstraZeneca Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 91. AstraZeneca Recent Developments
    Table 92. Celgene Corporation Company Details
    Table 93. Celgene Corporation Business Overview
    Table 94. Celgene Corporation Psoriasis Drugs Product
    Table 95. Celgene Corporation Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 96. Celgene Corporation Recent Developments
    Table 97. UCB Company Details
    Table 98. UCB Business Overview
    Table 99. UCB Psoriasis Drugs Product
    Table 100. UCB Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 101. UCB Recent Developments
    Table 102. Merck Company Details
    Table 103. Merck Business Overview
    Table 104. Merck Psoriasis Drugs Product
    Table 105. Merck Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 106. Merck Recent Developments
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Psoriasis Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Tumor Necrosis Factor Inhibitor Features
    Figure 3. Interleukin Inhibitors Features
    Figure 4. Others Features
    Figure 5. Global Psoriasis Drugs Market Share by Application: 2021 VS 2028
    Figure 6. Topicals Case Studies
    Figure 7. Systemic Case Studies
    Figure 8. Biologics Case Studies
    Figure 9. Psoriasis Drugs Report Years Considered
    Figure 10. Global Psoriasis Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Psoriasis Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Psoriasis Drugs Market Share by Region: 2021 VS 2028
    Figure 13. Global Psoriasis Drugs Market Share by Players in 2021
    Figure 14. Global Top Psoriasis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Drugs as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Psoriasis Drugs Revenue in 2021
    Figure 16. North America Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Psoriasis Drugs Market Size Market Share by Type (2017-2028)
    Figure 18. North America Psoriasis Drugs Market Size Market Share by Application (2017-2028)
    Figure 19. North America Psoriasis Drugs Market Size Share by Country (2017-2028)
    Figure 20. United States Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Psoriasis Drugs Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Psoriasis Drugs Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Psoriasis Drugs Market Size Share by Country (2017-2028)
    Figure 26. Germany Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Psoriasis Drugs Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Psoriasis Drugs Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Psoriasis Drugs Market Size Share by Region (2017-2028)
    Figure 36. China Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Psoriasis Drugs Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Psoriasis Drugs Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Psoriasis Drugs Market Size Share by Country (2017-2028)
    Figure 46. Mexico Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Psoriasis Drugs Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Psoriasis Drugs Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Psoriasis Drugs Market Size Share by Country (2017-2028)
    Figure 52. Turkey Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. AbbVie Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 56. Amgen Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 58. Novartis Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 59. Eli Lilly & Company Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 60. AstraZeneca Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 61. Celgene Corporation Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 62. UCB Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 63. Merck Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed